Pro- and anti-inflammatory biomarkers in non-alcoholic fatty liver disease and hypertension patients
| dc.contributor.author | Rozhdestvenska, Anastasiia | |
| dc.contributor.author | Zhelezniakova, Natalia | |
| dc.date.accessioned | 2023-05-20T15:50:26Z | |
| dc.date.available | 2023-05-20T15:50:26Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Non-alcoholic fatty liver disease (NAFLD) affects up to 50% of patients with hypertension (HT). The objective of our study was to assess the changes in anti-inflammatory systems (kallistatin, IL-10) and pro-inflammatory activity (IL-1β and high-sensitivity CRP (hsCRP)) in patients with NAFLD under the influence of concomitant HT. | en_US |
| dc.identifier.citation | Rozhdestvenska A. Pro- and anti-inflammatory biomarkers in non-alcoholic fatty liver disease and hypertension patients/ A. Rozhdestvenska, N. Zhelezniakova // 1st International Conference For Young Scientists – Biomarkers Of Civilization Diseases, April 21, 2023, Poland, Bialystok : Book of Abstracts. – Bialystok, 2023. – P. 94. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/32078 | |
| dc.language.iso | en | en_US |
| dc.subject | biomarkers | en_US |
| dc.subject | NAFLD | en_US |
| dc.subject | hypertension | en_US |
| dc.title | Pro- and anti-inflammatory biomarkers in non-alcoholic fatty liver disease and hypertension patients | en_US |
| dc.type | Thesis | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ICYS-2023-Rozhdestvenska_Zhelezniakova.pdf
- Size:
- 793.16 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 11.22 KB
- Format:
- Item-specific license agreed upon to submission
- Description: